Symbols

MD

Pediatrix Medical·NYSE

--(--)

MD fundamentals

MD Q4 2025 Earnings

Pediatrix Medical (MD) released its earnings on Feb 19, 2026: revenue was 493.77M (YoY -1.71%), beat estimates; EPS was 0.5 (YoY -1.96%), missed estimates.

Revenue / YoY

493.77M

-1.71%

EPS / YoY

0.5

-1.96%

Report date

Feb 19, 2026

MD Earnings Call Summary for Q4,2025

Strong Financials: 2025 EBITDA of $276M; 2026 guidance of $280-300M (+5% midpoint).
New Incentives: Physician alignment programs with stock grants for 500+ clinicians.
Flat Assumptions: 2026 revenue and pricing expected to remain steady.
Balance Sheet Strength: $375M cash, 1x net leverage, $64M share buybacks in Q4.
Growth Focus: OBH expansion and telemedicine leveraging existing NICU networks.

Earnings

EPS

Revenue

Revenue & Expenses

MD has released its 2025 Q4 earnings report, with revenue of 493.77M, reflecting a YoY change of -1.71%, and net profit of 33.68M, showing a YoY change of 10.51%. The Sankey diagram below clearly presents MD's revenue sources and cost distribution.

Key Indicators

Pediatrix Medical (MD) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Pediatrix Medical (MD)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Pediatrix Medical (MD)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Pediatrix Medical (MD)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown